Kantil Pharmaceuticals Private Limited - Company Profile

It is a pharma private limited company based in Delhi, Delhi, India, established in 2021.
2021 Delhi, Delhi, India Active
Last Updated:
Access Report
About Kantil Pharmaceuticals Private Limited

Kantil Pharmaceuticals Private Limited, a active private limited company, was established on 08 October 2021 in Delhi, Delhi, India. Engaging in drug formulation & development within the manufacturing sector, it holds CIN: U24230DL2021PTC387973. Registered under ROC Roc Delhi Ii. it is unlisted. It has an authorized capital of ₹3.50 M and a paid-up capital of ₹3.50 M.

It upholds a compliant status. Employing 33 professional, Its leadership includes Nitin Gupta (Director), Shikha (Director), Sarika Gupta (Director). Past directors included Sachin Gupta, Sarika Gupta. It holds ₹45.62 Cr open charges and ₹12.75 Cr settled loans. Its latest AGM occurred on 30 September 2025, with the balance sheet filed on 31 March 2025. It is based at 5, Raj Nagar, Pitam Pura, Delhi, Delhi, 110034.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U24230DL2021PTC387973

  • Registration Number

    387973

  • Incorporation Date

    08 October 2021

  • Authorized Capital

    ₹3.50 M

  • Paid-Up Capital

    ₹3.50 M

  • ROC Code

    Roc Delhi Ii

  • Listing Status

    Unlisted

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 3.50 M
  • Paid Up Capital ₹ 3.50 M
  • Company Age 4 Year, 4 Months
  • Last Filing with ROC 31 Mar 2025
  • Open Charges ₹ 45.62 Cr
  • Satisfied Charges ₹ 12.75 Cr
  • Revenue Growth **** 104.73%
  • Profit Growth **** -9434.03%
  • Ebitda **** -2563.36%
  • Net Worth -858.86%
  • Total Assets **** 117.82%
Company report

Kantil Pharmaceuticals Private Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Kantil Pharmaceuticals Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report
Who are the key members and board of directors at Kantil Pharmaceuticals Private Limited?
Current Directors
Name Designation Appointment Date Status
Nitin Gupta Director 08 Oct 2021 Current
Shikha Director 08 Oct 2021 Current
Sarika Gupta Director 08 Apr 2022 Current
Past Directors
Name Designation Cessation Status
Pramod Abcsdd Additional Director 30 Sep 2022 Past
Pramod Abcsdd Additional Director 30 Sep 2022 Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Kantil Pharmaceuticals.

Kantil Pharmaceuticals Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 104.73% increase. The company also saw a substantial fall in profitability, with a 9434.03% decrease in profit. The company's net worth observed a substantial decline by a decrease of 858.86%.

Kantil Pharmaceuticals revenue growth over time
Kantil Pharmaceuticals profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
 104.73%
*******
*******
*******
*******
Revenue from Operations
*******
 103.38%
*******
*******
*******
*******
Total Assets
*******
 117.82%
*******
*******
*******
*******
Profit or Loss
*******
 -9434.03%
*******
*******
*******
*******
Net Worth
*******
 -858.86%
*******
*******
*******
*******
EBITDA
*******
 -2563.36%
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Kantil Pharmaceuticals?

Unlock access to Kantil Pharmaceuticals's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

Charges (Loans)
Open Charges

₹456,249,000.00

Satisfied Charges

₹127,500,000.00

Charges Breakdown by Lending Institutions
  • Others : 42.85 Cr
  • Hdfc Bank Limited : 2.77 Cr
Latest Charge Details
Date Lender Amount Status
29 Dec 2025 Others ₹26.35 Cr Open
27 Mar 2025 Others ₹5.00 Cr Open
27 Mar 2025 Others ₹11.50 Cr Open
04 Mar 2023 Hdfc Bank Limited ₹0.73 M Open
06 Oct 2022 Hdfc Bank Limited ₹2.70 Cr Open

Explore comprehensive loan charge details -

How Many Employees Work at Kantil Pharmaceuticals?

Unlock and access historical data on people associated with Kantil Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Kantil Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Kantil Pharmaceuticals's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Kantil Pharmaceuticals
Recent Activity within the Organization
  • Charges

    The activity A charge with Others amounted to Rs. 263.50 M with Charge ID 101209918 was registered on 29 Dec 2025. was completed.

  • Annual General Meeting

    Progress on Kantil Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records. was documented.

  • Charges

    A charge registered on 29 Mar 2022 via Charge ID 100563338 with Hdfc Bank Limited was fully satisfied on 22 Jul 2025. was recorded as a recent event.

  • Balance Sheet

    Kantil Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Delhi Ii. was recorded as a recent event.

  • Charges

    Progress on A charge with Others amounted to Rs. 50.00 M with Charge ID 101078260 was registered on 27 Mar 2025. was documented.

  • Charges

    Progress on A charge with Others amounted to Rs. 115.02 M with Charge ID 101078274 was registered on 27 Mar 2025. was documented.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Kantil Pharmaceuticals Private Limited?

The CIN of Kantil Pharmaceuticals Private Limited is U24230DL2021PTC387973.

Where is Kantil Pharmaceuticals Private Limited headquartered?

Kantil Pharmaceuticals Private Limited is headquartered at 5, Raj Nagar, Pitam Pura, Delhi, Delhi, 110034.

When was Kantil Pharmaceuticals Private Limited incorporated?

Kantil Pharmaceuticals Private Limited was incorporated on 08 October 2021.

Who are the current directors of Kantil Pharmaceuticals Private Limited?

The current directors of Kantil Pharmaceuticals Private Limited are

What is the primary industry of Kantil Pharmaceuticals Private Limited?

The primary industry of Kantil Pharmaceuticals Private Limited is Manufacturing.

Is Kantil Pharmaceuticals Private Limited a listed company?

Kantil Pharmaceuticals Private Limited is unlisted.

What is the capital structure of Kantil Pharmaceuticals Private Limited?

The authorized capital of Kantil Pharmaceuticals Private Limited is ₹3.50 M, and the paid-up capital is ₹3.50 M.

What is the compliance status of Kantil Pharmaceuticals Private Limited?

The compliance status of Kantil Pharmaceuticals Private Limited is Compliant.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available